Recent breakthroughs in the field of molecular physiology have revealed that the secret to a long life might not reside within our inherited genes themselves, but rather in the microscopic molecules that govern how those genes are expressed over time. Researchers at the Duke Molecular Physiology
Ivan Kairatov is a leading biopharma and public health expert with extensive experience in research and development, particularly focusing on how technological innovation can be leveraged to combat infectious diseases. With a career spanning over a decade, he has become a pivotal voice in the
The sudden realization that a simple steak or a glass of milk could trigger a life-threatening emergency has become a terrifying reality for thousands of people across the American Midwest and beyond. This condition, known as alpha-gal syndrome (AGS), is not a typical food allergy born from
Expert Ivan Kairatov joins us to discuss the rapidly evolving landscape of health technology, specifically focusing on the safety and reliability of consumer-facing AI tools. As a biopharma expert with deep experience in research and development, Kairatov offers a unique perspective on the
The landscape of virtual medical services is undergoing a profound transformation as the digital health sector moves toward a unified model of care through high-stakes corporate consolidation. With the recent announcement that Him has entered into a definitive agreement to acquire Eucalyptus for a
The rapid evolution of molecular diagnostics has placed the promise of truly personalized healthcare within our reach, yet a significant disconnect remains between laboratory breakthroughs and the actual data available to bedside clinicians. Precision medicine relies on the seamless integration of
